z-logo
Premium
Fumonisin B1 alters cell cycle progression and interleukin‐2 synthesis in swine peripheral blood mononuclear cells
Author(s) -
Marin Daniela E.,
Gouze MarieEstelle,
Taranu Ionelia,
Oswald Isabelle P.
Publication year - 2007
Publication title -
molecular nutrition and food research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.495
H-Index - 131
eISSN - 1613-4133
pISSN - 1613-4125
DOI - 10.1002/mnfr.200700131
Subject(s) - peripheral blood mononuclear cell , fumonisin b1 , cell cycle , interleukin 2 , biology , lymphocyte , cd8 , cytokine , flow cytometry , cell growth , immunology , immune system , microbiology and biotechnology , cell , chemistry , biochemistry , in vitro , fusarium , horticulture
Fumonisin B 1 (FB 1 ) is a mycotoxin produced by Fusarium verticillioides, a fungus that commonly contaminates maize. In the present study, we investigated the effects of FB 1 on swine peripheral blood mononuclear cells (PBMC) by measuring cell proliferation, cell cycle progression and interleukin (IL)‐2 production. Forty‐eight hours after treatment in vitro , FB 1 induced a decrease of PBMC proliferation as measured by cell counting and dehydrogenase enzyme activity. This effect was observed starting with 10 μM FB 1 . The effect of FB 1 on cell cycle progression was analyzed by flow cytometry. Incubation of PBMC with FB 1 increased the percentage of cells blocked in G0/G1 phase of the cell cycle. Treatment with 200 μM FB 1 induces a high blockade of the cell cycle, with 92.4% of cells in G0/G1 phase. This blockade was observed in all lymphocyte subsets tested (CD2 + , CD4 + , CD8 + and Ig + ) as evidenced by dual staining for DNA and membrane surface molecules. A significant decrease of IL2 production was also observed in the supernatants of ConA stimulated PBMC treated with 100 or 200 μM FB 1 . In conclusion, these data suggest that FB 1 may affect immune functions by inhibiting lymphocyte proliferation and IL2 production, suggesting a possible role of FB 1 exposure during infectious disease and cancer.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom